BNTX 6-K: Acquisition

BioNTech SE

Filed with the SEC on Nov 10, 2026 · accession 0001776985-26-000083

BNTX filed a 6-K (foreign company report) with the SEC on Nov 10, 2026. How foreign companies listed in the US report news and events — like an 8-K for them.

Summary of the filing

BioNTech SE announced it has entered into an agreement to acquire a US FDA Priority Review Voucher (PRV) from Scholar Rock, Inc. for $205 million in cash.

For details, click here →How to read a 6-K →

Key details

Total cash consideration for FDA Priority Review Voucher$205.0M

AcquirerBioNTech SE

SellerScholar Rock, Inc.

Chief financial officerRamon Zapata-Gomez

Chief operating officerDr. Sierk Poetting

✦ Ask GOAX AI about this filing — what it means for BNTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BNTX?

Click here

Frequently asked questions

What did BNTX file with the SEC on Nov 10, 2026?

BNTX filed a 6-K (Acquisition). BioNTech SE announced it has entered into an agreement to acquire a US FDA Priority Review Voucher (PRV) from Scholar Rock, Inc. for $205 million in cash.

What does a acquisition mean for BNTX stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 6-K?

How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.

Other BNTX SEC filings

Get alerts when BNTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

BNTX overview BNTX analysis BNTX news Latest SEC filings